Ambuja Cements Limited (AMBUJACEM) — Financial Results | 3 November 2025(2 announcements)

· NSE 🔴 High Importance ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Ambuja Cements delivered robust Q2 FY26 results with consolidated net profit of ₹2,302 crores (up 364% YoY, including ₹1,697 crores tax reversal) and revenue of ₹9,174 crores (up 21% YoY). Cement sales volume reached 16.6 million tonnes (up 20% YoY), highest in Q2 series. EBITDA margin improved to 19.2% (up 4.5 percentage points YoY). The company raised FY28 capacity target from 140 MTPA to 155 MTPA via debottlenecking at USD 48/MT capex. Cost leadership initiatives reduced total costs 5% YoY, with kiln fuel and power costs down 2-6% respectively.

2 Financial Results 🔴 High Importance Neutral 📄 PDF

Ambuja Cements Limited submitted an audio recording of its analysts and investors conference call discussing unaudited financial results for Q2 and H1 FY2025-26 ended September 30, 2025. The company uploaded the web link to its investor relations portal for stakeholder access. This filing is a regulatory disclosure of the call recording rather than new financial data.

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMBUJACEM — Free

Free account · 2 AI queries/day